IP Library Assignment 036255/0778
Patent Assignment
Reel/Frame 036255/0778

Release of Security Interest

Recorded: 2015-08-05 Pages: 9
Assignor
MIDCAP FINANCIAL TRUST
Executed: 2015-07-29
Assignees
IMMUNE PHARMACEUTICALS, INC.
430 EAST 29TH STREET, SUITE 940, NEW YORK, NEW YORK, 10016
MAXIM PHARMACEUTICALS, INC.
8899 UNIVERSITY CENTER LANE, SUITE 400, SAN DIEGO, CALIFORNIA, 92122
CYTOVIA, INC.
6650 NANCY RIDGE DRIVE, SAN DIEGO, CALIFORNIA, 92121
Covered Properties (10)
4-Arylamino-Quinazolines and Analogs as Activators of Caspases and Inducers of Apoptosis and the Use Thereof
Patent: 7,618,975 →
Application: 10/885,903 →
Publication: US 2005/0137213
Compounds and Therapeutical Use Thereof
Application: 11/620,498 →
Publication: US 2007/0208044
Methods of Preparing Dosage Compositions Containing Substituted (4-Phenyl)-Methyl-(Quinazolin-4-Yl)-Amine Compounds
Application: 11/692,655 →
Publication: US 2007/0249632
Method of Treating Brain Cancer
Patent: 8,258,145 →
Application: 11/773,285 →
Publication: US 2008/0051398
Pharmaceutical Compounds as Activators of Caspases and Inducers of Apoptosis and the Use Thereof
Patent: 7,842,805 →
Application: 11/773,293 →
Publication: US 2008/0020985
4-Arylamin-Or-4-Heteroarylamino-Quinazolines and Analogs as Activators of Caspases and Inducers of Apoptosis and the Use Thereof
Patent: 7,989,462 →
Application: 11/773,303 →
Publication: US 2008/0004297
Compounds and Therapeutical Use Thereof
Patent: 8,309,562 →
Application: 12/500,863 →
Publication: US 2010/0069383
Pharmaceutical Compounds as Cytotoxic Agents and Uses Thereof
Application: 13/004,311 →
Publication: US 2011/0200619
Methods of Treating Cancer and Related Diseases
Application: 13/004,656 →
Publication: US 2011/0224240
Compounds and Therapeutical Uses Thereof
Application: 13/644,419 →
Publication: US 2013/0029942
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 20, 2004
From: PLEIMAN, CHRIS; BAICHWAL, VIJAY; MANFREDI, JOHN; BHOITE, LEENA
To: MYRIAD GENETICS, INC.
Reel/Frame 015151/0933 →
Assignment of Assignor's Interest Sep 20, 2004
From: CAI, SUI XIONG; SIRISOMA, NILANTHA SUDATH; PERVIN, AZRA; DREWE, JOHN A.
To: CYTOVIA, INC.
Reel/Frame 015152/0032 →
Assignment of Assignor's Interest Sep 13, 2007
From: ANDERSON, MARK B.; WILLARDSEN, ADAM; SUZUKI, KAZUYUKI
To: MYRIAD GENETICS, INC.
Reel/Frame 019823/0470 →
Assignment of Assignor's Interest Sep 18, 2007
From: CAI, SUI-XIONG; SIRISOMA, NILANTHA SUDATH; ZHANG, HONG
To: CYTOVIA, INC.
Reel/Frame 019844/0416 →
Assignment of Assignor's Interest Oct 4, 2007
From: ANDERSON, MARK B.; WILLARDSEN, ADAM
To: MYRIAD GENETICS, INC.
Reel/Frame 019922/0573 →
Assignment of Assignor's Interest Oct 4, 2007
From: CAI, SUI-XIONG; SIRISOMA, NILANTHA SUDATH
To: CYTOVIA, INC.
Reel/Frame 019922/0630 →
Assignment of Assignor's Interest Oct 4, 2007
From: CAI, SUI-XIONG; JIANG, SONGCHUN
To: CYTOVIA, INC.
Reel/Frame 019921/0773 →
Assignment of Assignor's Interest Oct 4, 2007
From: ANDERSON, MARK B.; WILLARDSEN, ADAM; HALTER, ROBERT J.; SLADE, RACHEL
To: MYRIAD GENETICS, INC.
Reel/Frame 019919/0932 →
Assignment of Assignor's Interest Aug 6, 2009
From: MYRIAD GENETICS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023061/0882 →
Assignment of Assignor's Interest Aug 24, 2009
From: MYRIAD GENETICS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023136/0158 →
Assignment of Assignor's Interest Aug 24, 2009
From: MYRIAD GENETICS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023136/0132 →
Assignment of Assignor's Interest Aug 24, 2009
From: MYRIAD GENETICS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023136/0172 →
Assignment of Assignor's Interest Aug 24, 2009
From: MYRIAD GENETICS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023137/0588 →
Assignment of Assignor's Interest Aug 24, 2009
From: MYRIAD GENETICS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023137/0716 →
Assignment of Assignor's Interest Nov 6, 2009
From: ANDERSON, MARK B.; WILLARDSEN, J. ADAM; WEINER, WARREN S.; YUNGAI, ASHANTAI
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023484/0145 →
Change of Name Aug 17, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024849/0119 →
Change of Name Aug 18, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024855/0711 →
Change of Name Aug 18, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024855/0508 →
Change of Name Aug 18, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024855/0213 →
Change of Name Aug 18, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024852/0911 →
Change of Name Aug 18, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024852/0657 →
Change of Name Aug 18, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024852/0481 →
Assignment of Assignor's Interest May 2, 2011
From: ANDERSON, MARK B.; KIM, IN CHUL
To: MYREXIS, INC.
Reel/Frame 026212/0135 →
Assignment of Assignor's Interest May 26, 2011
From: PLEIMAN, CHRISTOPHER M.; MATHER, GARY G.
To: MYREXIS, INC.
Reel/Frame 026348/0206 →
Security Agreement Feb 19, 2014
From: IMMUNE PHARMACEUTICALS INC.; MAXIM PHARMACEUTICALS, INC.; CYTOVIA, INC.
To: MIDCAP FUNDING III, LLC
Reel/Frame 032277/0353 →